|
Bioequivalence studies: |
|||
| 29 completed studies | |||
|
Indication |
International non-proprietary name |
||
|
Respiratory: |
•Sumamed, •Umamed forte, •Amosin, •Ambroxol (sol.) •Ambroxol (tab.) |
||
|
Pain syndrome: |
•Nimesulide | ||
|
Infectious diseases: |
•Tiloron | ||
| Urology: |
•Phosphomicin •Norfloxacin |
||
| Cardiology: | •Trimetazidin MV, Amlodipine + Ramipril | ||
| Dermatology: | •Itraconazole | ||
|
General therapy: |
•Levofloxacine,•Linezolid, •Cefotaxime, •Rivaroxaban, •Ibuprofen+Drotaverine, •Rosuvastin |
||
| Gastroenterology: | •Rabeprazol | ||
| Immunology: | •Rimantadin | ||
| Endocrinology: | •Metformin, Thioctic acid | ||
| Oncology: | •Imatinib | ||
|
Transplantology:
|
•Tacrolimus | ||
| Allergology: |
•Levocetirizin •Levocetirizin+Montelukast •Ketorolac |
||
|
Infectious disease:
|
•Linezolid | ||
|
Diabetic neuropathy:
|
•Berlithione | ||
